Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,639 public trials 303 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Active, Not Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV

NCT05903339

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Alabama CRS [Site ID: 31788] Birmingham, Alabama, United States
  • Emory University School of Medicine, The Ponce de Leon Center CRS [Site ID: 5802] Atlanta, Georgia, United States
  • Brigham & Women's Hospital [Site ID: 30007] Boston, Massachusetts, United States
  • BIDMC VCRS [Site ID: 32077] Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program

NCT05140421

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Alliance for Positive Change New York, United States
  • Mount Sinai Beth Israel New York, United States
  • Exponents, Inc. New York, United States
  • GMHC New York, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

NCT05996471

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

NCT04337450

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • King Edward VIII Hospital Durban, South Africa
  • PHRU Klerksdorp Klerksdorp, South Africa
  • PHRU Soweto, South Africa
  • Hospital Universitario 12 de Octubre Madrid, Spain
View all 14 locations
View Trial Details

Related conditions